Ebola and HIV are closely related in their social pathogenesis. The spread of both viruses is directly related to appalling governance of public heath systems and social inequality. Their control and treatment boils down to issues of democracy, equality and good governance.
21 hours ago | Daily Maverick
Jean-Claude Juncker has ceded to pressure from MEPs and abandoned his plan to return control of medicines and pharmaceutical products to the Industry Commissioner. This responsibility will instead remain in the hands of the Health Commissioner.
17 October 2014 | EurActiv
Earlier this month (October 2014) Public Health England and the Association of Directors of Public Health published a joint review of drug and alcohol commissioning in England and Wales. This Department of Health funded review was based on a series of interviews with Directors of Public Health (94% of the 152 Upper Tier authorities participated) and Drugscope and looked at current and future commissioning plans for drug and alcohol treatment.
17 October 2014 | Russell Webster (blog)
While making medications free can remove barriers to access for individuals who cannot pay for treatment, data suggest that for most people accessing care in industrialized countries, "making medications available for free or low cost will not solve problems with medication non-adherence," according to a presentation by Kevin Volpp from the University of Pennsylvania last week at IDWeek 2014 in Philadelphia.
16 October 2014 | HIVandHepatitis.com
More patients are going to their GP and telling them what treatment they need based on information from apps and the internet, a survey has suggested. A third of the UK physicians surveyed said patients would come with suggestions for what prescription they should receive, but fewer than 5% of doctors felt it was helpful.
02 October 2014 | BBC
The Thai Public Health Ministry has started distributing free antiretroviral drugs to all HIV patients in a move to expand treatment coverage and place them under the state's monitoring system. Previously, HIV patients would receive the drugs only if their number of CD4 cells — which mark the presence of HIV antibodies — decreased to 350, compared with 500 in normal people. From Wednesday, all HIV patients would have access to the drugs without the need for a CD4 count, Deputy Public Health Minister Somsak Chunharas said on Wednesday.
02 October 2014 | Bangkok Post
Morocco's human rights landscape is evolving for a number of reasons, many of which could have a positive effect on the way the country responds to its HIV epidemic. The right to access health services, the right to respect for human dignity, the right to discretion and privacy: all are becoming normative in the traditionally conservative Kingdom, which was among the only countries in the region that did not experience any upheaval during the Arab Spring.
02 October 2014 | Aidspan
Europe’s pharmaceutical industry has said it did not lobby for medicines and medical devices to be moved from the European Commission's health directorate (DG Sanco) to the enterprise directorate (DG Enterprise).
01 October 2014 | EurActiv
Among gay and bisexual men in the United States who have been diagnosed with HIV, only half are receiving care and treatment for their infection, according to a new analysis by the Centers for Disease Control and Prevention. And just 42 percent have achieved viral suppression – meaning their virus is under control at a level that helps keep them healthy and also greatly reduces their risk of transmitting HIV to others.
29 September 2014 | CDC press release
The concept note delivered on 8 September for Russia's last HIV grant from the Global Fund was a perfect illustration of the conundrum facing a growing number of Eastern European/Central Asian countries: how to do more with less to fight a widening HIV epidemic. As more countries from the region 'graduate' from Global Fund eligibility due to their income classification, the funds that they could once count on to support prevention, harm reduction and other programs targeting vulnerable populations are disappearing. And there is little evidence that most national budgets are prepared or able to fill the vacuum.
25 September 2014 | Aidspan